Activating glucokinase (GCK) mutations as a cause of medically responsive congenital hyperinsulinism: prevalence in children and characterisation of a novel GCK mutation. by Christesen, H, Tribble, N, Molven, A, Siddiqui, J, Sandal, T, Brusgaard, K, Ellard, S, Njølstad, P, Alm, J, Brock Jacobsen, B, Hussain, K, Gloyn, A

SUR mutation in type 1 diabetes: autoimmunity prevents sulfonylurea rescue of diabetes caused by SUR1 mutation. Results from the Hvidore Study Group by Porksen, S, Laborie, L, Nielsen, L, De Wet, H, Schvarcz, E, Sandal, T, Aman, J, Swift, P, Hougaard, P, Ashcroft, F, Molven, A, Knip, M, Hansen, L, Njolstad, P, Mortensen, H

Permanent neonatal diabetes due to mutations in KCNJ11 encoding Kir6.2: patient characteristics and initial response to sulfonylurea therapy. by Sagen, J, Raeder, H, Hathout, E, Shehadeh, N, Gudmundsson, K, Baevre, H, Abuelo, D, Phornphutkul, C, Molnes, J, Bell, G, Gloyn, A, Hattersley, A, Molven, A, Søvik, O, Njølstad, P

Disease progression and search for monogenic diabetes among children with new onset type 1 diabetes negative for ICA, GAD- and IA-2 Antibodies by Pörksen, S, Laborie, L, Nielsen, L, Louise Max Andersen, M, Sandal, T, De Wet, H, Schwarcz, E, Aman, J, Swift, P, Kocova, M, Schönle, E, de Beaufort, C, Hougaard, P, Ashcroft, F, Molven, A, Knip, M, Mortensen, H, Hansen, L, Njølstad, P